Neuroscience Market

Neuroscience Market (Technology: Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neuroproteomics Analysis, Animal Behavior Analysis, Neuro-functional Analysis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Neuroscience Market Outlook 2031

  • The global industry was valued at US$ 30.1 Bn in 2022
  • It is estimated to grow at a CAGR of 3.7% from 2023 to 2031 and reach US$ 41.6 Bn by the end of 2031

Analyst Viewpoint

Growth in incidence of degenerative neurological disorders is a prominent factor driving the global neuroscience market size. Technological advancements in the field of neuroscience such as generative AI, brain-computer interfaces, and portable MRI units are also fostering market expansion.

These technologies facilitate early detection of neurological disorders, thereby minimizing long-term impairments, as treatments are initiated by healthcare professionals during the prodromal phase.

Companies operating in the global neuroscience market are exploring the area of connectomics, which is the creation of detailed structural connectivity maps where every neuron can be seen clearly.

Leading players can use this information to devise further advanced technologies needed to study the context of human behavior, right from making decisions to executing them.

Market Introduction

Neuroscience refers to study of the nervous system, right from its structure, function, and development to degeneration. A human brain has 86 billion neurons. Neurobiology constitutes the study of the cells and tissues that form the nervous system.

Epilepsy, brain cancer, Alzheimer’s, and traumatic brain injuries constitute some of the neurological disorders. Brain function exploration is carried out through neuroimaging, which includes functional MRI and electroencephalography (EEG). Functional MRI and EEG are also used to review changes in brain activity.

Cognitive neuroscience entails the study of neural substrates of mental processes. It is the point of intersection between neuroscience and psychology.

Cognitive brain function exploration is generally recommended for the elderly population, as this population group is at a higher risk of age-related mental disorders such as Alzheimer’s and dementia.

Neuroscience industry growth revolves around delving deeper into cellular, behavioral, operative, molecular, evolutionary, and therapeutics aspects of the neuro system.

Increase in adoption of AI in the healthcare sector, especially in the neuroscience sphere, and constant developments in MRI machines such as introduction of smaller, portable, and cost-effective alternatives are some of the latest neuroscience market trends.

In conclusion, rise in prevalence of neurological diseases, growth in research-oriented support by academic & research institutes, and increase in funding by government and private agencies are boosting neuroscience market development.

Attribute Detail
Market Drivers
  • Increase in Prevalence of Degenerative Neurological Disorders
  • Advancements in Technologies

Growth in Prevalence of Degenerative Neurological Disorders Augmenting Neuroscience Market Demand

Increase in neurological disorders has become a prominent challenge for healthcare professionals worldwide. Rise in lifespan has led to a substantial increase in the geriatric population.

The elderly population is at a higher risk of contracting degenerative neurological disorders such as the Alzheimer's disease, Parkinson's disease, and multiple system atrophy.

According to the Alzheimer’s Association, nearly six million Americans aged 65 and above had Alzheimer’s in 2020. This figure is likely to reach 13 million by 2050.

As per the World Alzheimer Report published in 2021, more than 55 million individuals were suffering from dementia worldwide. The figure is expected to reach 78 million by 2030.

In 2021, the Brain Aneurysm Foundation revealed that more than 6.5 million individuals in the U.S. are battling unruptured brain aneurysm.

According to the World Federation of Neurology, neurological disorders are the second largest cause of fatality and one of the leading causes of disability at the global level. It further states that the medications available are insufficient for these disorders.

As per a paper published in The Lancet Neurology in October 2023, if measures for improving stroke surveillance and acute care are not taken, the number of people succumbing to stroke will increase by 50% across the globe.

Thus, surge in nervous system-related disorders is one of the leading neuroscience market drivers.

Advancements in Technologies Fueling Neuroscience Industry

Technological advancements are being incorporated in the neuroscience sector in order to improve neurofeedback systems.

The U.S. Government recently launched the Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) program for devising investigational methods to understand the working of the human brain.

Healthcare digitalization has also enabled better management of neurological disorders. In May 2023, Nicholas Opie and Dr. Thomas Oxley, Australia-based researchers, developed a human brain computer interface system to send data from the patient’s brain remotely for controlling external digital devices, thereby enabling paralyzed patients to communicate.

In May 2023, Koninklijke Philips N.V. introduced an AI-powered CT system called the Philips CT 3500 for executing high-volume screening programs. The device aims to deliver high quality images to radiologists for precise diagnosis.

Introduction of such brain-machine interface technologies in neuroscience is bolstering the neuroscience industry.

Neuroscience Market Regional Insights

Attribute Detail
Leading Region North America

North America held the largest neuroscience market share in 2022. The region is expected to maintain its dominance during the forecast period. This can be ascribed to availability of extensive funding by government agencies and private organizations alike for devising cutting-edge neuroscience research techniques in the region.

As per the National Institute of Health, funding for neurodegenerative diseases stood at US$ 4.1 Bn in 2021.

In May 2021, Sens.ai was introduced as the first at-home neuro optimization system that incorporated brain training with heart coherence training in order to help people manage stress.

Speedy approval of such innovative products from agencies such as the U.S. FDA is also driving market statistics in North America.

The neuroscience market forecast appears promising in Asia Pacific, led by the introduction of various initiatives in the field of neuroscience in countries such as China and India.

In September 2022, China introduced the China Brain Project (CBP) that focuses on brain-inspired computing, use of neuroinformatics and Big Data in neuroscience, therapeutic innovations in neurological disorders, and neuroimaging modalities and clinical applications.

Analysis of Key Players

Companies operating in the global neuroscience landscape are engaged in obtaining product approvals from regulatory bodies such as the U.S. FDA. They are also devising inorganic growth strategies to expand their offerings.

In May 2023, the U.S. FDA granted clearance to Neurophet AQUA, a brain MRI software that analyzes brain atrophy and white matter hyperintensities (WMH) observed in neurodegenerative diseases such as Alzheimer's disease and vascular dementia.

Noldus Information Technology BV, in June 2022, announced that it had entered into a collaborative agreement with Inscopix to access EthoVision XT video tracking software to be able to establish accurate correlations between rodent behavior and brain activity.

NEURALINK, Kernel, BrainCo, Inc., MindMaze, Paradromics, NeuroPro, NeuroSky, EMOTIV, Inc., Cercare Medical A/S, Plexon, Inc., Noldus Information Technology B.V., Femtonics Ltd., Neuralynx, Inc., Neurable, Inc., Bitbrain Technologies, Halo Neuroscience, and NeuroNexus Technologies, Inc. are some of the key players covered in the neuroscience market report.

These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Developments

  • In 2023, Philips launched a portable 1.5T MRI unit, which stands out due to its helium-free operations. It holds the distinction of being the first lightweight MRI machine.
  • In February 2022, NeuroNexus Technologies introduced NeuroNexus Summa Framework to enable life science researchers and experienced electrophysiologists to incorporate electrical signal read-outs from biological tissues and cells into their research

Neuroscience Market Snapshot

Attribute Detail
Market Size in 2022 US$ 30.1 Bn
Market Forecast (Value) in 2031 US$ 41.6 Bn
Growth Rate (CAGR) 3.7%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Component
    • Instrument
    • Software
    • Services
  • Technology
    • Whole Brain Imaging
    • Neuro-microscopy
    • Electrophysiology
    • Neuroproteomics Analysis
    • Animal Behavior Analysis
    • Neuro-functional Analysis
    • Others
  • End-user
    • Hospitals
    • Diagnostic Laboratories
    • Academic & Research Institutions
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • NEURALINK
  • Kernel
  • BrainCo, Inc.
  • MindMaze
  • Paradromics
  • NeuroPro
  • NeuroSky
  • EMOTIV, Inc.
  • Cercare Medical A/S
  • Plexon, Inc.
  • Noldus Information Technology B.V.
  • Femtonics Ltd.
  • Neuralynx, Inc.
  • Neurable, Inc.
  • Bitbrain Technologies
  • Halo Neuroscience
  • NeuroNexus Technologies, Inc.
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global neuroscience market in 2022?

It was valued at US$ 30.1 Bn in 2022

How is the neuroscience business expected to grow during the forecast period?

It is projected to grow at a CAGR of 3.7% from 2023 to 2031

What are the key factors driving the demand for neuroscience?

Growth in prevalence of degenerative neurological disorders and advancements in technologies

Which neuroscience end-user segment held the largest share in 2022?

The hospitals segment accounted for the largest share in 2022

Which region dominated the global neuroscience landscape in 2022?

North America was the dominant region in 2022

Who are the key players in the neuroscience industry?

NEURALINK, Kernel, BrainCo, Inc., MindMaze, Paradromics, NeuroPro, NeuroSky, EMOTIV, Inc., Cercare Medical A/S, Plexon, Inc., Noldus Information Technology B.V., Femtonics Ltd., Neuralynx, Inc., Neurable, Inc., Bitbrain Technologies, Halo Neuroscience, and NeuroNexus Technologies, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Neuroscience Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Neuroscience Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Neuroscience Market Analysis and Forecast, by Component

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Component, 2017–2031

            6.3.1. Instrument

            6.3.2. Software

            6.3.3. Services

        6.4. Market Attractiveness Analysis, by Component

    7. Global Neuroscience Market Analysis and Forecast, by Technology

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Technology, 2017–2031

            7.3.1. Whole Brain Imaging

            7.3.2. Neuro-microscopy

            7.3.3. Electrophysiology

            7.3.4. Neuroproteomics Analysis

            7.3.5. Animal Behavior Analysis

            7.3.6. Neuro-functional Analysis

            7.3.7. Others

        7.4. Market Attractiveness Analysis, by Technology

    8. Global Neuroscience Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Diagnostic Laboratories

            8.3.3. Academic & Research Institutions

            8.3.4. Others

        8.4. Market Attractiveness Analysis, by Technology

    9. Global Neuroscience Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Neuroscience Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Component, 2017–2031

            10.3.1. Instrument

            10.3.2. Software

            10.3.3. Services

        10.4. Market Value Forecast, by Technology, 2017–2031

            10.4.1. Whole Brain Imaging

            10.4.2. Neuro-microscopy

            10.4.3. Electrophysiology

            10.4.4. Neuroproteomics Analysis

            10.4.5. Animal Behavior Analysis

            10.4.6. Neuro-functional Analysis

            10.4.7. Others

        10.5. Market Value Forecast, by End-user, 2017–2031

            10.5.1. Hospitals

            10.5.2. Diagnostic Laboratories

            10.5.3. Academic & Research Institutions

            10.5.4. Others

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Component

            10.7.2. By Technology

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Neuroscience Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Component, 2017–2031

            11.3.1. Instrument

            11.3.2. Software

            11.3.3. Services

        11.4. Market Value Forecast, by Technology, 2017–2031

            11.4.1. Whole Brain Imaging

            11.4.2. Neuro-microscopy

            11.4.3. Electrophysiology

            11.4.4. Neuroproteomics Analysis

            11.4.5. Animal Behavior Analysis

            11.4.6. Neuro-functional Analysis

            11.4.7. Others

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Diagnostic Laboratories

            11.5.3. Academic & Research Institutions

            11.5.4. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Component

            11.7.2. By Technology

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Neuroscience Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Component, 2017–2031

            12.3.1. Instrument

            12.3.2. Software

            12.3.3. Services

        12.4. Market Value Forecast, by Technology, 2017–2031

            12.4.1. Whole Brain Imaging

            12.4.2. Neuro-microscopy

            12.4.3. Electrophysiology

            12.4.4. Neuroproteomics Analysis

            12.4.5. Animal Behavior Analysis

            12.4.6. Neuro-functional Analysis

            12.4.7. Others

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Diagnostic Laboratories

            12.5.3. Academic & Research Institutions

            12.5.4. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Component

            12.7.2. By Technology

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Neuroscience Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Component, 2017–2031

            13.3.1. Instrument

            13.3.2. Software

            13.3.3. Services

        13.4. Market Value Forecast, by Technology, 2017–2031

            13.4.1. Whole Brain Imaging

            13.4.2. Neuro-microscopy

            13.4.3. Electrophysiology

            13.4.4. Neuroproteomics Analysis

            13.4.5. Animal Behavior Analysis

            13.4.6. Neuro-functional Analysis

            13.4.7. Others

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Diagnostic Laboratories

            13.5.3. Academic & Research Institutions

            13.5.4. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Component

            13.7.2. By Technology

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Neuroscience Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Component, 2017–2031

            14.3.1. Instrument

            14.3.2. Software

            14.3.3. Services

        14.4. Market Value Forecast, by Technology, 2017–2031

            14.4.1. Whole Brain Imaging

            14.4.2. Neuro-microscopy

            14.4.3. Electrophysiology

            14.4.4. Neuroproteomics Analysis

            14.4.5. Animal Behavior Analysis

            14.4.6. Neuro-functional Analysis

            14.4.7. Others

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Diagnostic Laboratories

            14.5.3. Academic & Research Institutions

            14.5.4. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Component

            14.7.2. By Technology

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. NEURALINK

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Kernel

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. BrainCo, Inc.

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. MindMaze

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Paradromics

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. NeuroPro

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. NeuroSky

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. EMOTIV, Inc.

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

            15.3.9. Cercare Medical A/S

                15.3.9.1. Company Overview

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Financial Overview

                15.3.9.5. Strategic Overview

            15.3.10. Plexon, Inc.

                15.3.10.1. Company Overview

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Financial Overview

                15.3.10.5. Strategic Overview

            15.3.11. Noldus Information Technology B.V.

                15.3.11.1. Company Overview

                15.3.11.2. Product Portfolio

                15.3.11.3. SWOT Analysis

                15.3.11.4. Financial Overview

                15.3.11.5. Strategic Overview

            15.3.12. Femtonics Ltd.

                15.3.12.1. Company Overview

                15.3.12.2. Product Portfolio

                15.3.12.3. SWOT Analysis

                15.3.12.4. Financial Overview

                15.3.12.5. Strategic Overview

            15.3.13. Neuralynx, Inc.

                15.3.13.1. Company Overview

                15.3.13.2. Product Portfolio

                15.3.13.3. SWOT Analysis

                15.3.13.4. Financial Overview

                15.3.13.5. Strategic Overview

            15.3.14. Neurable, Inc.

                15.3.14.1. Company Overview

                15.3.14.2. Product Portfolio

                15.3.14.3. SWOT Analysis

                15.3.14.4. Financial Overview

                15.3.14.5. Strategic Overview

            15.3.15. Bitbrain Technologies

                15.3.15.1. Company Overview

                15.3.15.2. Product Portfolio

                15.3.15.3. SWOT Analysis

                15.3.15.4. Financial Overview

                15.3.15.5. Strategic Overview

            15.3.16. Halo Neuroscience

                15.3.16.1. Company Overview

                15.3.16.2. Product Portfolio

                15.3.16.3. SWOT Analysis

                15.3.16.4. Financial Overview

                15.3.16.5. Strategic Overview

            15.3.17. NeuroNexus Technologies, Inc.

                15.3.17.1. Company Overview

                15.3.17.2. Product Portfolio

                15.3.17.3. SWOT Analysis

                15.3.17.4. Financial Overview

                15.3.17.5. Strategic Overview

    List of Tables

    Table 01: Global Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031

    Table 02: Global Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 03: Global Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Neuroscience Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Neuroscience Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031

    Table 07: North America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 08: North America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031

    Table 11: Europe Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 12: Europe Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031

    Table 15: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 16: Asia Pacific Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031

    Table 19: Latin America Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 20: Latin America Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Component, 2017–2031

    Table 23: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by Technology, 2017–2031

    Table 24: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Neuroscience Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Neuroscience Market Revenue (US$ Mn), by Component, 2022

    Figure 03: Global Neuroscience Market Value Share, by Component, 2022

    Figure 04: Global Neuroscience Market Revenue (US$ Mn), by Technology, 2022

    Figure 05: Global Neuroscience Market Value Share, by Technology, 2022

    Figure 06: Global Neuroscience Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Global Neuroscience Market Value Share, by End-user, 2022

    Figure 08: Global Neuroscience Market Value Share, by Region, 2022

    Figure 09: Global Neuroscience Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Global Neuroscience Market Value Share Analysis, by Component, 2022–2031

    Figure 11: Global Neuroscience Market Attractiveness Analysis, by Component, 2023–2031

    Figure 12: Global Neuroscience Market Value Share Analysis, by Technology, 2022–2031

    Figure 13: Global Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 14: Global Neuroscience Market Value Share Analysis, by End-user, 2022–2031

    Figure 15: Global Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 16: Global Neuroscience Market Value Share Analysis, by Region, 2022–2031

    Figure 17: Global Neuroscience Market Attractiveness Analysis, by Region, 2023–2031

    Figure 18: North America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031

    Figure 19: North America Neuroscience Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Neuroscience Market Value Share Analysis, by Country, 2022–2031

    Figure 21: North America Neuroscience Market Value Share Analysis, by Component, 2022–2031

    Figure 22: North America Neuroscience Market Value Share Analysis, by Technology, 2022–2031

    Figure 23: North America Neuroscience Market Value Share Analysis, by End-user, 2022–2031

    Figure 24: North America Neuroscience Market Attractiveness Analysis, by Component, 2023–2031

    Figure 25: North America Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 26: North America Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Europe Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031

    Figure 28: Europe Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 30: Europe Neuroscience Market Value Share Analysis, by Component, 2022–2031

    Figure 31: Europe Neuroscience Market Value Share Analysis, by Technology, 2022–2031

    Figure 32: Europe Neuroscience Market Value Share Analysis, by End-user, 2022–2031

    Figure 33: Europe Neuroscience Market Attractiveness Analysis, by Component, 2023–2031

    Figure 34: Europe Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 35: Europe Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 36: Asia Pacific Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031

    Figure 37: Asia Pacific Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 39: Asia Pacific Neuroscience Market Value Share Analysis, by Component, 2022–2031

    Figure 40: Asia Pacific Neuroscience Market Value Share Analysis, by Technology, 2022–2031

    Figure 41: Asia Pacific Neuroscience Market Value Share Analysis, by End-user, 2022–2031

    Figure 42: Asia Pacific Neuroscience Market Attractiveness Analysis, by Component, 2023–2031

    Figure 43: Asia Pacific Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 44: Asia Pacific Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 45: Latin America Neuroscience Market Value (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031

    Figure 46: Latin America Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 48: Latin America Neuroscience Market Value Share Analysis, by Component, 2022–2031

    Figure 49: Latin America Neuroscience Market Value Share Analysis, by Technology, 2022–2031

    Figure 50: Latin America Neuroscience Market Value Share Analysis, by End-user, 2022–2031

    Figure 51: Latin America Neuroscience Market Attractiveness Analysis, by Component, 2023–2031

    Figure 52: Latin America Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 53: Latin America Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 54: Middle East & Africa Neuroscience Market Size (US$ Mn) Forecast, and Y-o-Y Growth (%), 2017–2031

    Figure 55: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Neuroscience Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 57: Middle East & Africa Neuroscience Market Value Share Analysis, by Component, 2022–2031

    Figure 58: Middle East & Africa Neuroscience Market Value Share Analysis, by Technology, 2022–2031

    Figure 59: Middle East & Africa Neuroscience Market Value Share Analysis, by End-user, 2022–2031

    Figure 60: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Component, 2023–2031

    Figure 61: Middle East & Africa Neuroscience Market Attractiveness Analysis, by Technology, 2023–2031

    Figure 62: Middle East & Africa Neuroscience Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved